Solve Therapeutics
About:
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.
Website: http://www.solvetherapeutics.com
Top Investors: General Atlantic, Surveyor Capital, Decheng Capital, Matrix Capital Management
Description:
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics. The company was founded in 2021 and is headquartered in Belmont, California.
Total Funding Amount:
$126M
Headquarters Location:
Belmont, California, United States
Founded Date:
2021-01-01
Founders:
Dave Johnson
Number of Employees:
11-50
Last Funding Date:
2022-01-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai